Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies

por Hibi, Toshifumi, Imai, Yuya, Murata, Yoko, Matsushima, Nobuko, Zheng, Richuan, Gasink, Christopher
Publicado 2017

Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn’s Disease and 2 Years in Ulcerative Coliti...

por Abraham, Bincy P, Ott, Elyssa, Busse, Christopher, Murphy, Conor, Miller, Lindsay, Baumgart, Daniel C, Scherl, Ellen, Gasink, Christopher
Publicado 2022

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis of Results from Phase 2/3 Studies

por Sandborn, William J, Feagan, Brian G, Danese, Silvio, O’Brien, Christopher D, Ott, Elyssa, Marano, Colleen, Baker, Thomas, Zhou, Yiying, Volger, Sheri, Tikhonov, Ilia, Gasink, Christopher, Sands, Bruce E, Ghosh, Subrata
Publicado 2020